Traws Pharma, Inc. - Common Stock (TRAW)

Traws Pharma, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutics to address unmet medical needs in various disease areas, including oncology and rare diseases

The company utilizes cutting-edge technology and scientific expertise to advance its pipeline of drug candidates, with a commitment to improving patient outcomes and enhancing quality of life. Through strategic partnerships and collaborations, Traws Pharma aims to accelerate the delivery of transformative treatments to the market while maintaining high standards of regulatory compliance and ethical practices in the pharmaceutical industry.